PG12 The omics revolution: the future of personalised medicine

Postgraduate Course
Chairs: R. Djukanovic (Southampton, United Kingdom), B. Crestani (Paris, France)
Aims: The aims of the course are to:
• Examine the limitations of current disease diagnosis;
• Explain what is meant by omics technologies;
• Provide evidence showing that combined omics analyses generate disease biomarkers;
• Show how omics analysis can predict clinical outcomes.

HERMES SYLLABUS LINKS
ADULT: Module D.3 Procedures performed collaboratively, Module E.1 Treatment modalities and prevention measures

---

Educational Material

How to access educational materials from mobile devices

---

Limitations of current clinical diagnosis: phenotype versus endotype P. J. Sterk (Amsterdam, The Netherlands)
Omics analysis can provide novel biomarkers of seasonal rhinitis M. Benson (Linkoping, Sweden)
Integrated omics predicts clinical outcomes R. Chen (Stanford, United States of America)